GFA
8783
Pluszero
5132
Silver Egg Technology
3961
Chiome Bioscience
4583
Pixel
2743
(Q2)Sep 20, 2024 | (Q1)Jun 20, 2024 | (FY)Mar 20, 2024 | (Q4)Mar 20, 2024 | (Q3)Dec 20, 2023 | (Q2)Sep 20, 2023 | (Q1)Jun 20, 2023 | (FY)Mar 20, 2023 | (Q4)Mar 20, 2023 | (Q3)Dec 20, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.22%7.79B | 14.01%7.04B | 4.19%28.47B | -3.51%5.87B | 3.44%8.81B | 4.39%7.62B | 13.74%6.18B | 9.95%27.33B | 6.65%6.08B | 22.99%8.51B |
Cost of revenue | 1.60%5.17B | 8.91%4.58B | 3.28%19.26B | -1.74%4.15B | 1.03%5.82B | 2.72%5.09B | 13.22%4.2B | 11.06%18.65B | 6.52%4.22B | 21.61%5.76B |
Gross profit | 3.48%2.62B | 24.87%2.47B | 6.16%9.21B | -7.52%1.72B | 8.49%2.99B | 7.92%2.53B | 14.86%1.97B | 7.63%8.68B | 6.95%1.86B | 25.98%2.75B |
Operating expense | 0.83%1.83B | 1.86%1.73B | 1.46%7.09B | -1.68%1.79B | 1.35%1.78B | 0.31%1.82B | 6.44%1.7B | 0.02%6.99B | 1.86%1.82B | 0.25%1.75B |
Staff costs | ---- | ---- | 0.32%3.36B | ---- | ---- | ---- | ---- | 0.96%3.35B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | 5.12%1.07B | ---- | ---- | ---- | ---- | -7.04%1.02B | ---- | ---- |
-Selling and marketing expense | ---- | ---- | 11.07%343.41M | ---- | ---- | ---- | ---- | -25.51%309.19M | ---- | ---- |
-General and administrative expense | ---- | ---- | 2.51%723.64M | ---- | ---- | ---- | ---- | 4.28%705.91M | ---- | ---- |
Depreciation and amortization | ---- | ---- | 2.20%431.18M | ---- | ---- | ---- | ---- | -7.29%421.92M | ---- | ---- |
-Depreciation | ---- | ---- | 3.50%274.1M | ---- | ---- | ---- | ---- | 13.04%264.84M | ---- | ---- |
-Amortization | ---- | ---- | 0.00%157.08M | ---- | ---- | ---- | ---- | -28.86%157.08M | ---- | ---- |
Other operating expenses | ---- | ---- | 1.36%2.23B | ---- | ---- | ---- | ---- | 3.77%2.2B | ---- | ---- |
Operating profit | 10.30%781.53M | 168.59%731.83M | 25.54%2.13B | -242.89%-64.39M | 20.98%1.21B | 33.99%708.52M | 127.02%272.47M | 56.77%1.69B | 205.06%45.07M | 128.93%1B |
Net non-operating interest income (expenses) | 515.96%25.93M | 31.58%-5.96M | 1,665.29%43.74M | 104.57%70.2M | -130.48%-21.96M | 137.19%4.21M | 20.78%-8.71M | 133.40%2.48M | 47.49%34.32M | 3.26%-9.53M |
Non-operating interest income | ---- | ---- | 81.42%77.06M | ---- | ---- | ---- | ---- | 28.12%42.47M | ---- | ---- |
Non-operating interest expense | -24.76%7.12M | -31.58%5.96M | -16.71%33.31M | -15.96%6.85M | -13.01%8.29M | -16.40%9.46M | -20.78%8.71M | -1.42%40M | -17.49%8.16M | -3.26%9.53M |
Net investment income | 11.45%23.57M | 16.64%15.84M | 16.33%50.77M | -19.15%-2.03M | 13.94%18.07M | 19.39%21.15M | 15.35%13.58M | -28.12%43.64M | -110.33%-1.7M | 1.35%15.86M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 381.52%886K | 886K | 108.08%184K | 0 | 285K | |||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -293.77%-1.06M | -4,699.39%-14.99M | -752.94%-834.05M | -677.73%-834.92M | -3K | -94.29%546K | 326K | 32.27%-97.79M | 26.19%-107.35M | 0 |
Less:Other special charges | ---- | ---- | 138.79%2.64M | 26.57%3.51M | --3K | ---546K | ---326K | -1,599.50%-6.8M | 312.20%2.77M | --0 |
Less:Write off | --1.06M | --14.99M | 694.97%831.42M | ---- | ---- | --0 | --0 | -27.76%104.58M | ---- | ---- |
Other non-operating income (expenses) | -497.73%-76.94M | 65.51%26.78M | -58.27%31.55M | -215.28%-66.12M | 112.80%62.15M | -64.16%19.35M | 20.77%16.18M | 44.82%75.6M | 31.81%-20.97M | 25.05%29.21M |
Income before tax | -0.10%753.04M | 156.42%753.49M | -17.37%1.42B | -1,669.69%-896.38M | 22.42%1.27B | 25.90%753.77M | 119.14%293.84M | 65.29%1.72B | 72.04%-50.65M | 122.42%1.04B |
Income tax | -0.03%258.83M | 78.67%237.84M | 28.27%706.4M | -510.13%-99.48M | 30.75%413.85M | 35.13%258.91M | 125.94%133.12M | 16.31%550.72M | -150.91%-16.3M | 87.60%316.51M |
Net income | -0.13%494.21M | 220.82%515.65M | -38.90%713.57M | -2,220.11%-796.91M | 18.76%854.89M | 21.55%494.87M | 113.82%160.73M | 106.25%1.17B | 80.34%-34.35M | 142.18%719.84M |
Net income continuous operations | -0.13%494.21M | 220.83%515.65M | -38.90%713.57M | -2,220.10%-796.91M | 18.76%854.88M | 21.55%494.87M | 113.81%160.73M | 106.25%1.17B | 80.34%-34.35M | 142.18%719.84M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -0.13%494.21M | 220.82%515.65M | -38.90%713.57M | -2,220.11%-796.91M | 18.76%854.89M | 21.55%494.87M | 113.82%160.73M | 106.25%1.17B | 80.34%-34.35M | 142.18%719.84M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -0.13%494.21M | 220.82%515.65M | -38.90%713.57M | -2,220.11%-796.91M | 18.76%854.89M | 21.55%494.87M | 113.82%160.73M | 106.25%1.17B | 80.34%-34.35M | 142.18%719.84M |
Gross dividend payment | ||||||||||
Basic earnings per share | -4.92%32.11 | 219.75%35.14 | -39.09%48.67 | -2,185.29%-54.39 | 18.38%58.3 | 21.13%33.77 | 112.98%10.99 | 105.58%79.91 | 80.18%-2.38 | 141.42%49.25 |
Diluted earnings per share | -4.92%32.11 | 219.75%35.14 | -39.09%48.67 | -2,185.29%-54.39 | 18.38%58.3 | 21.13%33.77 | 112.98%10.99 | 105.58%79.91 | 80.18%-2.38 | 141.42%49.25 |
Dividend per share | 0 | 0 | -20.00%8 | -20.00%8 | 0 | 0 | 0 | 25.00%10 | 25.00%10 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |